Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2009 Apr;92(2):177-83.
doi: 10.1007/s11060-008-9750-y. Epub 2008 Nov 29.

A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience

Affiliations
Clinical Trial

A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience

Paola Fidani et al. J Neurooncol. 2009 Apr.

Abstract

Purpose: Atypical Teratoid/Rhabdoid Tumour is a rare and aggressive childhood tumour. The outcome of a series treated with the same multimodal strategy was reported.

Patients: The patients were treated with surgery, 2 courses of ifosfamide/carboplatin/etoposide(ICE), 2 courses of cyclophosphamide/etoposide/carboplatino/thiotepa (CECAT) or 2 other ICE courses, high dose chemotherapy (HDC) and radiotherapy.

Results: Eight patients underwent primary surgery achieving a complete removal in 3. Progressive disease (PD) occurred in 2/8 patients during ICE courses and in 3/4 during CECAT courses. After 4 courses 5 patients presented a PD. HDC was performed in 3 patients followed by local radiotherapy. The Kaplan Meier OS and EFS probability at 5 years are, respectively, 50% (CI 11-80%) and 33% (CI 6-66%).

Conclusion: A strategy based on surgery, including a second surgical look, and on radiotherapy appears the best option. ICE regimen and HDC correlate with good prognosis in some patients but this approach needs further evaluation.

PubMed Disclaimer

References

    1. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1038-43 - PubMed
    1. Am J Surg Pathol. 1998 Sep;22(9):1083-92 - PubMed
    1. J Neurooncol. 2005 Mar;72(1):77-84 - PubMed
    1. Cancer. 2005 Apr 25;105(2):65-70 - PubMed
    1. J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 - PubMed

Publication types

MeSH terms